Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

GSK Looking To Extend Tykerb

March 2007 | Company Finance Alert

UK-based drugmaker GlaxoSmithKline (GSK) has announced that it is experimental cancer drug Tykerb (lapatinib) will shortly enter advanced clinical trials for the treatment of tumours to the head and neck. The drug has already been filed with the US FDA and European regulator as a breast cancer drug, with industry observers confident that it could match

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
NHS Not Keen On Cancer Drugs

Companies / United Kingdom Doctors in the UK have expressed doubt that state-run healthcare provider the National Health Service (NHS) will be able to afford the new generation of cancer drugs that are entering the market. A questionnaire...
May 2007
Alliance Boots: A Look To The Future

Companies / United Kingdom With the dust settling on Stefano Pessina's successful GBP11.1bn (US$22.08bn) take-over of Alliance Boots , BMI takes a look at look at what the future is likely to hold for the retailer. The deal...
April 2007
R&D On The Up

Companies / United Kingdom A new report from the Association of the British Pharmaceutical Industry (ABPI) suggests that the UK is punching above its weight in terms of drug development. In 2006, there were 951 compounds in clinical...
April 2007
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS